1. Academic Background The COVID-19 pandemic has highlighted the importance of immunoregulatory mechanisms in respiratory viral infections. Despite vaccine advancements, the rapid mutation of SARS-CoV-2 continues to threaten public health. Studies indicate that severe COVID-19 cases are often associated with dysregulated immune responses rather tha...

Academic Background Alzheimer’s disease (AD) is the most common neurodegenerative disorder among the elderly, characterized by the pathological features of amyloid-beta (Aβ) deposits and hyperphosphorylated tau protein. Although aging is the most prominent risk factor for AD, the cellular mechanisms linking the decline in neuronal proteostasis to t...

Academic Background Doxorubicin (Dox) is an anthracycline drug widely used in the treatment of tumors, but it exhibits dose-dependent cardiotoxicity, potentially leading to cardiomyopathy and heart failure. Despite its significant anticancer effects, the cardiotoxicity of Dox limits its clinical application. Currently, Dexrazoxane is the only FDA-a...

Study on Congenital Immune Dysfunction in Cystic Fibrosis Research Background Cystic Fibrosis (CF) is a genetic disease caused by mutations in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene, primarily affecting the lungs and digestive system. One of the major problems faced by CF patients is recurrent infections and inflammatio...

DNA Hypomethylation-Mediated Upregulation of GADD45B Facilitates Airway Inflammation and Epithelial Cell Senescence in COPD Academic Background Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous disease characterized by chronic airway inflammation and irreversible airflow limitation, and it is one of the leading causes of death worldwi...